Octapharma

Headquartered in Lachen, Switzerland, Octapharma is one of the world's largest human protein manufacturers, specializing in proteins derived from human plasma and cell lines. As a leading industry player, our products serve therapeutic roles in hospitals and are used as excipients across various applications. Biotechnology firms globally depend on our products for manufacturing, research, and cell culture media. For more than a decade, we have been a trusted partner, offering regulatory, technical, and quality support for our pharmaceutical-grade offerings, which are approved by both the EMA and FDA, produced in compliance with GMP guidelines, and adhere to USP and EP standards. Octapharma operates seven R&D sites, along with five advanced manufacturing facilities located in Austria, France, Germany, and Sweden. Additionally, we manage over 195 plasma donation centers across Europe and the US, leveraging 40 years of experience in patient care across Immunotherapy, Hematology, and Critical Care.